Skip to content
Open access

DAST-28 severity and injection-related harm risks among people using psychoactive substances in psychiatric and correctional settings in Mongolia: a multicenter cross-sectional study

Aug 2026 · Addictive Behaviors Reports · Vol 24 · 0 citations · 19 references
Medicine

Abstract

Introduction Evidence on drug-related problem severity and injection-related harm among people using psychoactive substances in Mongolia is limited, particularly in institutional settings. We examined DAST-28 scores, internal consistency, and behavioral correlates in psychiatric and correctional settings. Methods This multicenter cross-sectional study included 181 participants recruited from the National Center for Mental Health and correctional facilities. The continuous DAST-28 total score was the primary outcome. Internal consistency was evaluated from 28 item responses. A clinically specified seven-covariate linear model with HC3 heteroskedasticity-robust standard errors was primary; ordinal and study-defined DAST-28 ≥ 12 models were supportive analyses. Results DAST-28 scores were available for 179 participants (median 11.0, interquartile range 6.0–16.0). Among 170 participants with complete item responses, Cronbach's alpha was 0.882 (95% bootstrap confidence interval 0.854–0.902). In the primary model, correctional setting was associated with a 1.82-point lower score (95% CI -3.36 to −0.28), whereas each additional year of use (B = 0.27, 95% CI 0.08–0.45), polysubstance use (B = 2.64, 95% CI 0.79–4.50), and any syringe use (B = 4.43, 95% CI 2.58–6.28) were associated with higher scores. Ordinal and threshold analyses were concordant; variance inflation factors ranged from 1.05 to 1.59. Conclusions Greater DAST-28 scores were associated with polysubstance use, syringe use, and longer use duration in these institutional samples. The findings may inform comprehensive assessment and harm-reduction linkage but do not establish a diagnostic cutoff, causal relationship, intervention effectiveness, or population prevalence.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.